Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07195097 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sildosin as a Male Contraceptive Non Hormonal

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 26, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Benha University
124 trials monitored
See 3 trials at risk
In all, 200 healthy, sexually active, fertile male candidates will be assigned 100 in silodosin group and 100 in placebo group. Males using other contraceptive methods will be excluded. Follow up data of total spermatozoa per ejaculate, semen volume and Post-ejaculation urinalysis after 2, 6 and 12 weeks of the studied groups will be recorded. The various side effects reported in the study groups after 12 weeks from the start of the study will be recorded.
Trial Details
NCT Number NCT07195097
Lead Sponsor Benha University
Conditions
(from sponsor)		 Contraception Use
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov